PUBLICATION

Zebrafish larvae as a model to demonstrate secondary iron overload

Authors
Nasrallah, G.K., Younes, N.N., Baji, M.H., Shraim, A.M., Mustafa, I.
ID
ZDB-PUB-180130-12
Date
2018
Source
European journal of haematology   100(6): 536-543 (Journal)
Registered Authors
Nasrallah, Gheyath
Keywords
chelators, deferoxamine, iron, thalassemia, zebrafish
MeSH Terms
  • Animals
  • Chelation Therapy
  • Deferoxamine/pharmacology
  • Deferoxamine/therapeutic use
  • Disease Models, Animal
  • Immunohistochemistry
  • Iron/metabolism
  • Iron Chelating Agents/therapeutic use
  • Iron Overload/diagnosis
  • Iron Overload/drug therapy
  • Iron Overload/etiology*
  • Iron Overload/metabolism*
  • Larva
  • Mass Spectrometry
  • Zebrafish
  • beta-Thalassemia/complications
PubMed
29377279 Full text @ Eur. J. Haematol.
Abstract
Thalassemia is the most common genetically inherited blood disorder arising from a defect in hemoglobin production, resulting in ineffective erythropoiesis and severe hemolytic anemia. While transfusion therapy corrects the anemia, it gives rise to secondary iron overload. Current iron chelation therapy performed using deferoxamine, and the efficiency of this drug was demonstrated here using the zebrafish animal model.
Zebrafish larvae were exposed for 3 days to iron [100 μmol L-1 ferric ammonium citrate; 3-6 days post fertilization (dpf)]. Then, iron treated larvae were exposed to 100 μmol L-1 deferoxamine for 3 days (6-9 dpf). Total tissue iron concentration in the whole larvae, assessed by three different assays; inductively coupled plasma mass spectrometry, colorimetry (spectrophotometry), and microscopy using iron staining followed by imaging and quantification.
The three assays showed that iron treatment alone resulted in a significant increase in total iron. Deferoxamine treatment of the iron-loaded zebrafish larvae showed a significant decrease in total iron concentration.
This study presented a clear evidence of the effectiveness of zebrafish larvae to use as a tool to study iron overload and open the door for studying the efficiency of potential new iron chelating compounds other than commercially available ones.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping